JNJ vs IDXX
By Alex · Tickerpine
Johnson & Johnson vs IDEXX Laboratories, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | IDXX |
|---|---|---|
| Price | $254.66 | $551.50 |
| Market cap | $613.02B | $43.50B |
| P/E ratio | 29.5 | 40.6 |
| ROE | 26.42% | 72.91% |
| Profit margin | 21.83% | 24.63% |
| Revenue growth | 9.90% | 14.30% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 1.54 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs IDXX in plain English
- JNJ is the bigger company — about 14.1× the market cap of IDXX.
- JNJ is cheaper on earnings (P/E 29.5 vs 40.6).
- IDXX earns a higher return on equity (73% vs 26%).
- IDXX is growing revenue faster (14% vs 10%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
IDXX return calculator
See what $1,000 in IDEXX Laboratories, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.